Transcript della relazione sugli utili: Milestone Pharmaceuticals raggiunge le previsioni EPS, titolo in calo
Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Milestone Pharmaceuticals (NASDAQ:MIST)